REDMILE GROUP
REDMILE GROUP, LLC Legal Name
Adviser information for REDMILE GROUP last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 35 |
---|---|
Investment Advisory/Research | 20 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 27 | $6.5B |
Non-Discretionary | 0 | $0 |
Total | 27 | $6.5B |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 27 | $6.5B |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 52 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
ONE LETTERMAN DRIVEBLDG D, STE D3-300
SAN FRANCISCO
CA
United States
Monday - Friday, 7:00 A.M. - 4:00 P.M.
Tel: 415-489-9980, Fax: 415-520-5516
Websites
Chief Compliance Officer
JENNIFER CIRESI
GENERAL COUNSEL
ONE LETTERMAN DRIVE
BLDG D, STE D3-300
SAN FRANCISCO
CA
United States
Tel:
415-489-9980
J*******@*************M
(Full email address available in API data)
Industry Affiliates
RAF GP, LLC | Sponsor, GP, manager of pooled investment vehicles |
REDCO I (GP), LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
REDCO II (GP), LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
REDMILE BIOPHARMA INVESTMENTS I (GP), LLC | Sponsor, GP, manager of pooled investment vehicles |
REDMILE BIOPHARMA INVESTMENTS II (GP), LLC | Sponsor, GP, manager of pooled investment vehicles |
REDMILE BIOPHARMA INVESTMENTS III (GP), LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
REDMILE GROUP (GP) III, LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
REDMILE GROUP (GP) IV, LLC | Sponsor, GP, manager of pooled investment vehicles |
REDMILE GROUP (GP), LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
REDMILE GROWTH INVESTMENTS I (GP), LLC | Sponsor, GP, manager of pooled investment vehicles |
REDMILE PRIVATE INVESTMENTS I (GP), LLC | Sponsor, GP, manager of pooled investment vehicles |
REDMILE PRIVATE INVESTMENTS II (GP), LLC | Sponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
RAF, L.P. | Venture Capital Fund | $260.9M | $50.0M | 2 |
REDCO I, L.P. | Hedge Fund | $109.3M | $5.0M | 52 |
REDCO II MASTER FUND, L.P. | Hedge Fund | $1,518.8M | $10.0M | 41 |
REDMILE BIOPHARMA INVESTMENTS I, L.P. | Venture Capital Fund | $142.8M | $2.0M | 80 |
REDMILE BIOPHARMA INVESTMENTS II, L.P. | Venture Capital Fund | $828.5M | $5.0M | 138 |
REDMILE BIOPHARMA INVESTMENTS III, L.P. | Private Equity Fund | $1,152.2M | $5.0M | 330 |
REDMILE CAPITAL FUND, LP | Hedge Fund | $654.2M | $5.0M | 348 |
REDMILE CAPITAL OFFSHORE FUND (ERISA), LTD. | Hedge Fund | $55.2M | $5.0M | 24 |
REDMILE CAPITAL OFFSHORE II MASTER FUND, LTD. | Hedge Fund | $961.5M | $1.0M | 8 |
REDMILE CAPITAL OFFSHORE MASTER FUND, LTD. | Hedge Fund | $729.3M | $5.0M | 217 |
REDMILE GROWTH INVESTMENTS I, L.P. | Venture Capital Fund | $156.8M | $5.0M | 3 |
REDMILE PRIVATE INVESTMENTS I AFFILIATES, L.P. | Venture Capital Fund | $11.9M | $2.0M | 17 |
REDMILE PRIVATE INVESTMENTS I, L.P. | Venture Capital Fund | $15.9M | $2.0M | 11 |
REDMILE PRIVATE INVESTMENTS II, L.P. | Venture Capital Fund | $61.6M | $2.0M | 29 |
REDMILE STRATEGIC LONG ONLY TRADING SUB, LTD. | Hedge Fund | $285.8M | $5.0M | 47 |
REDMILE STRATEGIC TRADING SUB, LTD. | Hedge Fund | $211.9M | $5.0M | 115 |
RM SPECIAL HOLDINGS 4, LLC | Private Equity Fund | $44.9M | $5.0M | 10 |
RM SPECIAL HOLDINGS 8, LLC | Private Equity Fund | $1.2M | $5.0M | 2 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
GREEN, JEREMY, CHARLES | Individual | – | MANAGING MEMBER | 03/2007 | 50-75% |
GARCIA, JOSHUA, DAMIAN | Individual | – | CHIEF FINANCIAL OFFICER | 01/2014 | < 5% |
CRAPO, BRYAN, RANNEY | Individual | – | CHIEF OPERATING OFFICER | 01/2014 | 5-10% |
LEE, MICHAEL, STEWART | Individual | – | MANAGING DIRECTOR | 01/2014 | 10-25% |
FAULKNER, ROBERT, CARRINGTON | Individual | – | MANAGING DIRECTOR | 01/2014 | 5-10% |
NAGPAL, AMRIT, NMN | Individual | – | MANAGING DIRECTOR | 01/2019 | < 5% |
LEARY, OWEN, JOHN | Individual | – | MANAGING DIRECTOR | 01/2019 | < 5% |
CIRESI, JENNIFER, KATE | Individual | – | GENERAL COUNSEL AND CHIEF COMPLIANCE OFFICER | 03/2022 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
4D MOLECULAR THERAPEUTICS IN | COM | 23M | 1M | – |
89BIO INC | COM | 14M | 2M | – |
ABSCI CORPORATION | COM | 25M | 8M | – |
AC IMMUNE SA | SHS | 7M | 2M | – |
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 1M | 2M | – |
ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | 698K | 716K | – |
ADC THERAPEUTICS SA | SHS | 48M | 15M | – |
AKERO THERAPEUTICS INC | COM | 38M | 2M | – |
ALLAKOS INC | COM | 3M | 3M | – |
ALLOVIR INC | COM | 1M | 2M | – |
ALPHA TEKNOVA INC | COM | 212K | 155K | – |
ALX ONCOLOGY HLDGS INC | COM | 24M | 4M | – |
AMICUS THERAPEUTICS INC | COM | 105M | 11M | – |
ANNEXON INC | COM | 31M | 6M | – |
ARDELYX INC | COM | 14M | 2M | – |
ATARA BIOTHERAPEUTICS INC | COM NEW | 4M | 452K | – |
AUGMEDIX INC | COM | 14M | 16M | – |
BEAM THERAPEUTICS INC | COM | 40M | 2M | – |
BIOHAVEN LTD | COM | 38M | 1M | – |
BLUEPRINT MEDICINES CORP | COM | 10M | 94K | – |
BOSTON SCIENTIFIC CORP | COM | 30M | 390K | – |
BOUNDLESS BIO INC | COM | 4M | 1M | – |
CABALETTA BIO INC | COM | 3M | 443K | – |
CATALENT INC | COM | 33M | 596K | – |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 27M | 719K | – |
COGENT BIOSCIENCES INC | COM | 40M | 5M | – |
CYTOKINETICS INC | COM NEW | 6M | 112K | – |
ENTRADA THERAPEUTICS INC | COM | 8M | 561K | – |
ESTABLISHMENT LABS HLDGS INC | COM | 10M | 213K | – |
FATE THERAPEUTICS INC | COM | 43M | 13M | – |
GRITSTONE BIO INC | COM | 3M | 5M | – |
HOOKIPA PHARMA INC | COM | 630K | 1M | – |
IDEAYA BIOSCIENCES INC | COM | 27M | 760K | – |
IGM BIOSCIENCES INC | COM | 21M | 3M | – |
IMMUNOME INC | COM | 59M | 5M | – |
IMMUNOVANT INC | COM | 19M | 720K | – |
INTUITIVE SURGICAL INC | COM NEW | 18M | 40K | – |
INVIVYD INC | COM | 3M | 3M | – |
KEROS THERAPEUTICS INC | COM | 25M | 553K | – |
KRYSTAL BIOTECH INC | COM | 188M | 1M | – |
KYMERA THERAPEUTICS INC | COM | 47M | 2M | – |
LAVA THERAPEUTICS NV | SHS | 4M | 2M | – |
LIVANOVA PLC | SHS | 51M | 930K | – |
NEUROGENE INC | COM | 37M | 1M | – |
NURIX THERAPEUTICS INC | COM | 92M | 4M | – |
NUVATION BIO INC | COM CL A | 9M | 3M | – |
PLIANT THERAPEUTICS INC | COM | 35M | 3M | – |
PRIME MEDICINE INC | COM | 11M | 2M | – |
RAPT THERAPEUTICS INC | COM | 2M | 537K | – |
REGENXBIO INC | COM | 53M | 5M | – |
REPARE THERAPEUTICS INC | COM | 6M | 2M | – |
REPLIMUNE GROUP INC | COM | 50M | 6M | – |
SCHOLAR ROCK HLDG CORP | COM | 45M | 5M | – |
SHATTUCK LABS INC | COM | 22M | 6M | – |
SILENCE THERAPEUTICS PLC | ADS | 38M | 2M | – |
STANDARD BIOTOOLS INC | COM | 729K | 412K | – |
STEREOTAXIS INC | COM NEW | 4M | 2M | – |
STOKE THERAPEUTICS INC | COM | 64M | 5M | – |
STRYKER CORPORATION | COM | 13M | 39K | – |
VENTYX BIOSCIENCES INC | COM | 5M | 2M | – |
VERVE THERAPEUTICS INC | COM | 7M | 1M | – |
XERIS BIOPHARMA HOLDINGS INC | COM | 2M | 1M | – |
ZYMEWORKS INC | COM | 44M | 5M | – |